Ignite Creation Date:
2025-12-24 @ 12:06 PM
Ignite Modification Date:
2026-02-21 @ 11:18 PM
Study NCT ID:
NCT03660761
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2018-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
Sponsor:
Rongjie Tao
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-06
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-11
First Submit QC Date:
None
Study First Post Date:
2018-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-14
Last Update Post Date:
2019-04-16
Last Update Post Date Type:
ACTUAL